source
- Ionis shares tumble over $1 billion as Tryngolza sales forecast cut in halfIonis Pharmaceuticals saw its market value drop by more than $1 billion after it lowered its sales outlook for Tryngolza, a triglyceride‑lowering therapy. The company now expects $50 million in sa…
- Opinion: STAT+: BIO CEO: American biotech needs a coordinated plan to beat China — nowBIO CEO: “Today’s biotech race is our generation’s Space Race.”STAT · 1h ago↗ source
- Opinion: AI’s health advice can be accurate and still make us sicker“Even a factually accurate health message can change behavior in ways that make people less healthy,” researchers write.